These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22565957)

  • 1. A work in progress.
    Polvino B
    Nat Biotechnol; 2012 May; 30(5):388-9. PubMed ID: 22565957
    [No Abstract]   [Full Text] [Related]  

  • 2. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the business of culture.
    Pissarra Pde N
    Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 5. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 6. Too little, too late: when is the right time for new leadership in biotech?
    Branthwaite P; Williams SJ
    Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591
    [No Abstract]   [Full Text] [Related]  

  • 7. Public biotechnology 2002--the numbers.
    Lähteenmäki R; DeFrancesco L
    Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 11. The view from the top.
    Howard K
    Nature; 2003 Dec; 426(6967):696-7. PubMed ID: 14668873
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Biotech in the financial crisis.
    Jungbauer A
    Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
    [No Abstract]   [Full Text] [Related]  

  • 13. Public biotechnology 2001--the numbers.
    Lähteenmäki R; Fletcher L
    Nat Biotechnol; 2002 Jun; 20(6):551-5. PubMed ID: 12042853
    [No Abstract]   [Full Text] [Related]  

  • 14. Recruiters and industry. Dual competencies.
    Rousselle T
    Nature; 2004 Jul; 430(6998):488. PubMed ID: 15269780
    [No Abstract]   [Full Text] [Related]  

  • 15. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 16. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 17. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 18. Can China's supply of scientific talent keep up with demand?
    Wong G
    Nat Biotechnol; 2008 Feb; 26(2):243-4. PubMed ID: 18259182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing talent needs to realize biotech products.
    Rafferty MA
    Nat Biotechnol; 2004 Oct; 22(10):1327. PubMed ID: 15470474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.